ADDITIONAL COSTS RELATED TO ORAL JANUS KINASE INHIBITOR USE IN ATOPIC DERMATITIS

被引：0
|
作者：
Robinson, Stephen [1 ]
Kallala, Rami [1 ]
Jo-Hansen, Christian Dall [2 ]
Panek, Malgorzata [3 ]
Nikodem, Mateusz [3 ]
Chudzik, Kamila [3 ]
Damentko, Magdalena [4 ]
Brandi, Henrik [5 ]
机构：
[1] Leo Pharma UK, Maidenhead, Berks, England
[2] Leo Pharma AS, Copenhagen, Denmark
[3] Putnam PHMR, Krakow, Poland
[4] Putnam PHMR, Warsaw, Poland
[5] Leopharma AS, Copenhagen, Denmark
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P5.6
引用
收藏
页码：33 / 34
页数：2
相关论文
共 50 条
  • [31] Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
    Singh, Rhea
    Heron, Courtney E.
    Ghamrawi, Rima, I
    Strowd, Lindsay C.
    Feldman, Steven R.
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 255 - 272
  • [32] Janus kinase inhibitors for atopic dermatitis: a promising treatment modality
    Cartron, A. M.
    Nguyen, T. H.
    Roh, Y. S.
    Kwatra, M. M.
    Kwatra, S. G.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 820 - 824
  • [33] The Rate of Infections With Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-Analysis
    Tarafdar, Nawar
    Sachdeva, Muskaan
    Dubale, Natnaiel M.
    Smythe, Ciaran
    Lytvyn, Yuliya
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) : 83 - 85
  • [34] Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic Dermatitis
    De, Surya K. K.
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (38) : 4278 - 4282
  • [35] Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab
    Yang, Nali
    Chen, Lele
    Shao, Junyi
    Jiang, Fan
    Liu, Jingjing
    Li, Zhiming
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (05) : 828 - 830
  • [36] The risk of infections with janus kinase inhibitor treatment for atopic dermatitis: a systematic review and meta-analysis
    Tarafdar, N.
    Sachdeva, M.
    Dubale, N.
    Smythe, C.
    Lytvyn, Y.
    Maliyar, K.
    Georgakopoulos, J.
    Mufti, A.
    Yeung, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S338 - S338
  • [37] A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
    Haag, Carter
    Alexis, Andrew
    Aoki, Valeria
    Bissonnette, Robert
    Blauvelt, Andrew
    Chovatiya, Raj
    Cork, Michael J.
    Danby, Simon G.
    Eichenfield, Lawrence F.
    Eyerich, Kilian
    Gooderham, Melinda
    Guttman-Yassky, Emma
    Hijnen, Dirk-Jan
    Irvine, Alan D.
    Katoh, Norito
    Murrell, Dedee F.
    Leshem, Yael A.
    Levin, Adriane A.
    Vittrup, Ida
    Olydam, Jill, I
    Orfali, Raquel L.
    Paller, Amy S.
    Renert-Yuval, Yael
    Rosmarin, David
    Silverberg, Jonathan, I
    Thyssen, Jacob P.
    Stander, Sonja
    Stefanovic, Nicholas
    Todd, Gail
    Yu, JiaDe
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [38] A review of major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : E69 - E69
  • [39] Baricitinib, an oral reversible Janus kinase 1 and 2 inhibitor, for atopic dermatitis: Head and neck response across two phase 3 studies
    Simpson, Eric
    Bissonnette, Robert
    Nunes, Fabio P.
    Rueda, Maria Jose
    Paul, Carle
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB28 - AB28
  • [40] Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications
    Chang, Po-Hsiung
    Huang, Sheng-Fen
    Chang, Po-Sheng
    Yu, Yu
    JOURNAL OF DERMATOLOGY, 2021, 48 (11): : 1631 - 1639
12345